News

Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.
Recent cuts to the CDC are affecting women suffering from chronic diseases. In April, the group that was responsible for evaluating research and recommending birth control methods for patients with ...
Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of ...
Victoria Gray, the first person cured of sickle cell using CRISPR gene editing therapies, spoke in Fargo about her journey and the need to lower the $2M treatment cost.
MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, announced today that it will present new ...
ShareThe Acting Vice-Chancellor of Yakubu Gowon University, Abuja, formerly UniAbuja, Prof. Patricia Lar has said that ...
Sickle Cell Disease is the most common inherited blood disorder in the United States, affecting the lives of 100,000 people, ...
Even if children with sickle cell disease appear asymptomatic, it's still crucial to provide proper care, says columnist.
The team responsible for updating the CDC’s “contraception bible,” which advises doctors on birth control safety, was ...
Without the Sickle Cell Data Collection program, we will see greater burdens and higher costs for both families and health ...
A specialised centre for this debilitating genetic disorder has opened its doors, offering swift and comprehensive treatment ...